On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...